What Cancers Is Proton Therapy Used For? (2026 Update)

Proton therapy is a particle radiation treatment that accelerates hydrogen nuclei and directs them at a tumor. It is mainly used for pediatric cancers, tumors located next to structures that must not be damaged — such as the eyes, brain, or spinal cord — localized tumors like hepatocellular carcinoma, some lung cancers, and esophageal cancer, and recurrences in areas previously treated with radiation.

Key Takeaways

• Proton therapy is classified as a type of particle radiation therapy, and its biological effect in killing cancer cells is similar to that of conventional X-ray radiation (National Cancer Center Korea).
• Because protons stop at a set depth (the Bragg peak), almost no radiation reaches normal tissue behind the tumor — this reduced damage to surrounding tissue is its main strength.
• Main candidates are pediatric cancers; tumors next to the eyes, brain, spinal cord, or skull base (head and neck cancer, brain tumors, chordoma, ocular melanoma); localized tumors such as hepatocellular carcinoma, some lung cancers, and esophageal cancer; and recurrences in areas previously treated with radiation.
• Cancers that have spread to multiple organs (metastatic disease) or blood cancers are not standard indications — if metastasis is present, systemic therapy takes priority (NCCN patient guidelines).
• Treatment typically involves 10–35 sessions delivered 5 days a week, starting 1–2 weeks after planning, with a total stay of about 4–7 weeks.

Which Cancers and Stages Is It Suitable For?

• Proton therapy is generally considered in four situations: pediatric cancers, where protecting normal tissue in a still-growing body is critical; tumors next to structures that cannot easily recover if damaged (eyes, brain, spinal cord, skull base); localized tumors such as hepatocellular carcinoma, some lung cancers, and esophageal cancer, where surrounding normal organs must be spared; and recurrences in areas that previously received radiation therapy.
• In terms of stage, the main candidates are localized or locally advanced disease. Cancers that have spread to multiple organs, as well as blood cancers such as leukemia and lymphoma, are not standard indications. When metastasis is present, systemic therapy comes first, and proton therapy is not typically the first choice even for symptom relief.
• NCCN patient guidelines note that protecting normal tissue is an important consideration in pediatric tumors, since children's growing bodies carry a relatively higher risk of growth impairment or secondary cancers in normal tissue exposed to radiation.

How Does It Differ From Conventional Radiation Therapy and Carbon-Ion Therapy?

• X-rays pass through the body, depositing energy in tissue both in front of and behind the tumor, whereas protons stop at the target depth and virtually no radiation continues beyond it. The cancer-killing power itself is similar to conventional radiation; the difference lies in delivering the same dose to the tumor while reducing the dose to surrounding tissue.
• Carbon-ion therapy is a particle therapy that uses carbon ions, which are heavier than protons and cause stronger breaks in cancer cell DNA, making it useful even for tumors that respond poorly to conventional radiation. Neither is simply "better" — each is suited to different cases: proton therapy when protecting normal tissue is the priority, and carbon-ion therapy when radiation resistance is the main issue.
• The treatment process includes 1–2 weeks for simulation imaging, fixation device fabrication, and treatment planning, followed by 10–35 sessions delivered 5 days a week; each visit, including setup, takes around 30 minutes.

What About Side Effects and Recovery?

• There is no pain during irradiation. Common reactions are fatigue and skin changes at the treatment site; other effects depend on the area treated. Treatment to the head can cause hair loss in that area; head and neck treatment may cause mouth sores, dry mouth, or taste changes; chest treatment may cause swallowing discomfort or coughing; and pelvic treatment may cause changes in urination or bowel movements.
• Most of these resolve over the following weeks, and patients can typically return home within a few days of the final session. Response to treatment is assessed with imaging over several months, and for children, growth and hormone function need to be monitored long-term — a follow-up plan is included in the handoff summary for the local medical team.

FAQ — Can children receive proton therapy?

Yes. Pediatric cancer is one of the leading indications for proton therapy, since it is especially important to minimize radiation exposure to normal tissue in a growing child's body. Because the treatment requires the patient to stay completely still, sedation may be needed — in which case a pediatric anesthesia team is involved, and families are given meal and sleep schedules to help align sedation timing each day.

FAQ — Can an area that already received radiation therapy be treated again?

If you bring records of the radiation dose and treatment area you previously received, the review stage can determine whether treatment can continue in that area or whether a new plan is needed. Whether re-irradiation is possible depends on the previous treatment site, total dose, number of fractions, and treatment dates — so these records are the key documents needed.

Sources and Notes

• This article was written based on explanations of proton therapy, carbon-ion therapy, and radiation therapy from National Cancer Center Korea and NCCN patient guidelines.
• This content is provided for general medical information purposes only; actual diagnosis, treatment methods, and outcomes may vary depending on individual condition. Please consult a medical professional for an accurate diagnosis and treatment decision.